Neogen (NEOG) Non-Current Debt (2011 - 2026)
Neogen's (NEOG) quarterly Non-Current Debt came in at $793.3 million in Q1 2026, down 10.93% year-on-year from $890.6 million in Q1 2025, and little changed quarter-over-quarter from $792.9 million in Q4 2025.
Neogen (NEOG) Non-Current Debt (2011 - 2026) Analysis & Trends
Neogen's Non-Current Debt history runs 12 years deep, the most recent figure standing at $793.3 million for Q1 2026.
- On a quarterly basis, Non-Current Debt fell 10.93% year-over-year to $793.3 million in Q1 2026; TTM through Feb 2026 was $793.3 million, a 10.93% decrease from a year earlier, with the FY2025 full-year figure at $874.8 million, down 1.53% from the prior year.
- Non-Current Debt steadied at $793.3 million in Q1 2026 per NEOG's latest filing, from $792.9 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $924.0 million in Q4 2022 and bottomed at $792.5 million in Q3 2025.
- The 5-year median for Non-Current Debt is $886.5 million (2023), against an average of $869.0 million.
- Across the five-year window, Non-Current Debt grew 0.33% in 2024 and slipped 10.93% in 2026, its largest moves.
- Year by year, Non-Current Debt stood at $924.0 million in 2022, then declined by 4.01% to $886.9 million in 2023, then rose by 0.33% to $889.9 million in 2024, then slipped by 10.89% to $792.9 million in 2025, then rose by 0.05% to $793.3 million in 2026.
- Per Business Quant, the three latest NEOG Non-Current Debt figures stand at $793.3 million (Q1 2026), $792.9 million (Q4 2025), and $792.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn | 10.13 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | 3.18 Bn |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 8.07 Bn |
| 10 | Neogen | 2.07 Bn | 1.91 Bn | 99.00 Mn | 793.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 793.30 Mn |
| Nov 30, 2025 | 792.93 Mn |
| Aug 31, 2025 | 792.53 Mn |
| May 31, 2025 | 874.80 Mn |
| Feb 28, 2025 | 890.61 Mn |
| Nov 30, 2024 | 889.87 Mn |
| Aug 31, 2024 | 889.13 Mn |
| May 31, 2024 | 888.39 Mn |
| Feb 29, 2024 | 887.65 Mn |
| Nov 30, 2023 | 886.92 Mn |
| Aug 31, 2023 | 886.18 Mn |
| May 31, 2023 | 885.44 Mn |
| Feb 28, 2023 | 884.70 Mn |
| Nov 30, 2022 | 923.96 Mn |
| Feb 28, 2017 | 3.23 Mn |
| Nov 30, 2016 | 2.25 Mn |
| Aug 31, 2016 | 2.22 Mn |
| May 31, 2016 | 2.42 Mn |
| Feb 29, 2016 | 2.11 Mn |
| Nov 30, 2015 | 2.18 Mn |